Insider · CIK 0001870437
Brett Matthew Hall
Files at IMRX (Immuneering Corp). First filing Jun 24, 2025, latest Jun 16, 2026.
Brett Matthew Hall files SEC Form 4 as officer at IMRX (Immuneering Corp). Since Jun 24, 2025, Brett Matthew Hall has reported 3 open-market buys worth $70k and 0 open-market sells worth $0, the latest filed on Jun 16, 2026.
A track record needs three past buys with six months of prices behind them; Brett Matthew Hall has 2, so none is measured yet.
The newest scored trade: bought $25k of IMRX on Jun 15, 2026, filed Jun 16, 2026, scored 36 (weak). In the last 12 months: 2 buys worth $36k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMRX: Immuneering Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Immuneering Corp | $25k 6,035 shares | +2% | +130% from low-55% from high | |
| 33Weak | Immuneering Corp | $11k 2,298 shares | +1% | +322% from low-50% from high | |
| 36Weak | Immuneering Corp | $35k 13,422 shares | +4% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +6,035 | $4.15 | $25k | 382,531 | Jun 16, 2026 |
| Feb 3, 2026 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +344,000 | $0.00 | $0 | 344,000 | Feb 5, 2026 |
| Jan 15, 2026 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +2,298 | $4.57 | $11k | 376,496 | Jan 16, 2026 |
| Sep 15, 2025 | IMRX Immuneering Corp | AGrant or award Class A Common Stock | +14,880 | $1.43 | $21k | 374,198 | Sep 17, 2025 |
| Jun 20, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +7,415 | $2.70 | $20k | 353,311 | Jun 24, 2025 |
| Jun 23, 2025 | IMRX Immuneering Corp | POpen-market purchase Class A Common Stock | +6,007 | $2.43 | $15k | 359,318 | Jun 24, 2025 |
| Feb 5, 2025 | IMRX Immuneering Corp | AGrant or award Stock Optionderivative | +240,000 | $0.00 | $0 | 240,000 | Feb 7, 2025 |
Questions about Brett Matthew Hall
Answered from the filings on this page, as of the latest one.
Is Brett Matthew Hall buying or selling?
In the last 12 months Brett Matthew Hall reported 2 open-market buys worth $36k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of IMRX on Jun 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Brett Matthew Hall's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brett Matthew Hall has 2.
Where does Brett Matthew Hall file Form 4?
Brett Matthew Hall has filed Form 4 at IMRX (Immuneering Corp) as CHIEF SCIENTIFIC OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.